Haixi Pharmaceutical International Holdings Limited

Proposed ASX code: HXP

Proposed listing date: Application Withdrawn

Company contact details Haixi Pharmaceutical International Holdings Ltd
Ph: 08 9389 8033
Principal Activities Engages in the development, manufacturing, research and development and sale of pharmaceutical products.
GICS industry group TBA
Issue Price $0.50
Issue Type Fully Paid Ordinary Shares
Security code HXP
Capital to be Raised $30 million
Expected offer close date 29 September 2017
Underwriter n/a

# Listings dates are proposed dates for first quotation of securities set out in the entity's prospectus or information memorandum. You may not rely on this information in any way.
## Listing dates are anticipated dates for first quotation of securities set by ASX following completion of admission procedures. However, they are subject to change without notice and you may not rely on this information in any way.